TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $170,263 | +5.2% | 11,006 | +6.8% | 0.05% | +11.6% |
| Q2 2023 | $161,829 | +55.8% | 10,301 | +63.5% | 0.04% | +48.3% |
| Q1 2023 | $103,857 | +16.6% | 6,302 | +10.3% | 0.03% | +16.0% |
| Q4 2022 | $89,092 | +20.4% | 5,711 | -0.2% | 0.02% | 0.0% |
| Q3 2022 | $74,000 | -7.5% | 5,722 | 0.0% | 0.02% | -3.8% |
| Q2 2022 | $80,000 | +207.7% | 5,722 | +292.5% | 0.03% | +188.9% |
| Q3 2020 | $26,000 | -7.1% | 1,458 | 0.0% | 0.01% | -10.0% |
| Q2 2020 | $28,000 | +21.7% | 1,458 | -5.6% | 0.01% | 0.0% |
| Q1 2020 | $23,000 | -20.7% | 1,544 | +5.2% | 0.01% | -9.1% |
| Q4 2019 | $29,000 | +11.5% | 1,467 | -1.1% | 0.01% | +10.0% |
| Q3 2019 | $26,000 | +4.0% | 1,484 | +6.2% | 0.01% | 0.0% |
| Q2 2019 | $25,000 | -10.7% | 1,398 | 0.0% | 0.01% | -9.1% |
| Q1 2019 | $28,000 | – | 1,398 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |